{"pub_date": "2016-08-23T04:00:00+0000", "subsection_name": "DealBook", "lead_paragraph": "A heated auction and back-of-the-envelope math hint that the buyer is overpaying.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CYRAN", "firstname": "Robert", "role": "reported"}], "original": "By ROBERT CYRAN"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Breakingviews", "main": "The Flaws in Pfizer\u2019s Plan to Acquire Medivation", "kicker": "Breakingviews"}, "source": "The New York Times", "blog": [], "word_count": "376", "web_url": "http://www.nytimes.com/2016/08/23/business/dealbook/the-flaws-in-pfizers-plan-to-acquire-medivation.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "A heated auction and back-of-the-envelope math hint that the buyer is overpaying....", "_id": "57bb5b0295d0e021d798203d", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Pfizer Inc", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Medivation Inc", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "5", "name": "organizations", "value": "Astellas Pharma", "is_major": "N"}]}